New drug approvals are reshaping the landscape of Eosinophilic Esophagitis (EoE) treatment
The FDA has granted approval for two medications in the treatment of Eosinophilic Esophagitis (EoE)—the first oral medication tailored for adults and the exclusive therapeutic option for children. Evan Dellon, MD, MPH, internationally known for his work with EoE, and colleagues continue to focus on optimizing usage for effective, personalized outcomes. Eosinophilic Esophagitis (EoE) is … Read more